Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
06/2003
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/04/2003EP1017395A4 Method for treating premenstrual or late luteal phase syndrome
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/28/2003EP1314755A2 Ultraviolet radiation absorbents for thermoplastic polymers and methods of producing the same
05/28/2003EP1314729A1 Biologically active 4H-benzo(1,4)oxazin-3-ones
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/28/2003EP1169300B1 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
05/28/2003EP0736019B1 1,3-oxazin-4-one derivatives, process and intermediates for their preparation and their use as herbicides
05/28/2003CN1420137A UV absorbent for thermoplastic polymer and producing process thereof
05/28/2003CN1109499C Fungicide active substance combinations
05/27/2003CA2090063C Surfactant composition and method of making same
05/22/2003WO2003042211A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003WO2003042196A1 Benzoxazineshaving polymerizable side groups, thermosetting resi ns comprised thereof, and methods for use thereof
05/22/2003WO2003042195A2 Photochromic oxazine compounds and methods for their manufacture
05/22/2003US20030096992 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/22/2003US20030096889 Low color, low sodium benzoxazinone UV absorbers and process for making same
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003CA2467267A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003CA2467074A1 Photochromic oxazine compounds and methods for their manufacture
05/21/2003EP1312600A1 Process for separating mixtures of crude, water-containing amines originating from the amine synthesis
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566358 Cyclocarbamate derivatives as progesterone receptor modulators
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003US6565830 DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092711 Contraceptives; hormone replacement therapy
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030089592 Process for fractionating water-containing crude amine mixtures from amine synthesis
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/14/2003EP1309572A1 Silent mark for oil product and detection method thereto
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1140888B1 Optical molecular sensors for cytochrome p450 activity
05/14/2003CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors
05/14/2003CN1418209A Carbocyclic side chain containing metalloprotease inhibitors
05/13/2003US6562815 Morpholinones as light stabilizers
05/13/2003US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/07/2003EP1308443A2 Method for the preparation of aryl ethers
05/07/2003EP1307432A1 Cyclic oxyguanidine protease inhibitors
05/07/2003EP0730738B1 Metal chelate containing compositions for use in chemiluminescent assays
05/07/2003CN1107505C Synergistic combination of AIDS antiviral compounds and HIV inhibitor
05/06/2003US6559145 Heterocycle carboxamides as antiviral agents
05/06/2003US6559144 Integrin inhibitors used to treat circulatory disorders, for thrombosis, myocardial infarct, coronary heart disease, arteriosclerosis, osteoporosis, pathological processes maintained or propagated by angiogenesis and tumor therapy
05/06/2003US6559143 Class III electrophysiological activity, drugs which prolong the trans-membrane action potential duration and refractoriness, without affecting cardiac conduction
05/06/2003US6559100 2-benzoyl-cyclohexane-1,3-diones
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1305300A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments
05/01/2003WO2003035735A1 Low color, low sodium benzoxazinone uv absorbers and process for making same
05/01/2003WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
05/01/2003US20030083490 Coupling of H-phosphonate with a nucleoside alcohol to form the diester; oxidation with sulfur transfer agent to form a phosphorothioate triester
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003US20030083329 Biologically active 4H-benzo [1,4] oxazin-3-ones
04/2003
04/29/2003US6555536 Antiproliferative agents; antidiabetic agents
04/24/2003WO2003033481A1 Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them
04/24/2003WO2003033456A1 NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS
04/24/2003WO2003032731A1 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
04/24/2003US20030078265 Inhibitors of nitric oxide synthase (nos)
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030077635 Dendrimer for use as diagnostic tools in chemical analysis
04/24/2003CA2463686A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
04/24/2003CA2463685A1 Novel .beta.-phenyl-.alpha.-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
04/23/2003CN1106389C Efficient enantioselective addition reaction using organozinc reagent
04/17/2003WO2003031482A1 Method for crosslinking hydrogels with morpholine-2,3-diones
04/17/2003WO2003031458A1 Methods for synthesis of diarylmethanes
04/17/2003WO2003031431A1 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/16/2003EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/16/2003EP1301493A2 Heterocycle carboxamides as antiviral agents
04/16/2003EP1015436B1 Morpholinones as light stabilizers
04/16/2003EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
04/15/2003US6548666 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
04/15/2003US6548534 Hydroxy and amine or amide compounds with substitution pattern on the aryl radical; can be used alone or in combination with estrogens in contraceptive preparations for treating gynecological disorders and premenstrual symptoms
04/15/2003US6548471 Perfluoroaminoperfluoroalkyl hydrocarbyl ethers such as perfluoro(3-(piperidin-1-yl)propyl) methyl ether; for solvent cleaning applications, with low ozone depletion potential
04/15/2003CA2097715C Indan derivatives
04/10/2003WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases
04/10/2003WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 112